FDA approves first topical treatment for vitiligo

 The U.S. Food and Drug Administration has approved Opzelura (ruxolitinib) as the first topical treatment for vitiligo.

The 1.5 percent cream is approved ...more

Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a severe autoimmune disease that predominantly affects young women. SLE is characterized...more